Secretion of Gastrin and Calcitonin after Ingestion of Meat Extract in Patients with Peptic Ulcer
スポンサーリンク
概要
- 論文の詳細を見る
Serum gastrin and calcitonin were determined after administration of meat extract to patients with peptic ulcer in order to investigate what role gastrin and calcitonin are playing in peptic ulcer. Serum gastrin levels were elevated after ingestion of meat extract in 9 out of 11 patients with peptic ulcer. Serum calcitonin (CT) levels were elevated rather gradually in 7 subjects. It wassuggested that increased endogenous gastrin levels may have stimulated the release of CT. When salmon calcitonin (SCT) was administered intravenously at a dose of 100 MRCu before administration of meat extract, the rise of gastrin and CT was suppressed in 67% of cases as to gastrin and in 43% as to CT.
- 社団法人 日本内分泌学会の論文
著者
-
Nishizawa Yoshiki
Second Department Of Internal Medicine Osaka City University Medical School
-
NOZAKI KANJI
Second Department of Internal Medicine, Osaka City University Medical School
-
MORII HIROTOSHI
Second Department of Internal Medicine Osaka City University
-
WADA MASAHISA
Second Department of Internal Medicine Osaka City University Meaical School
-
NODA SHIN-ICHI
Second Department of Internal Medicine, Osaka City University Medical School
-
OBI SABURO
Second Department of Internal Medicine, Osaka City University Medical School
関連論文
- -0146- Role of endothelium in hypotensive action of acetylcholine and bradylinin in spontaneously hypertensive rat.(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- Efficacy and safety of long-term oral falecalcitriol treatment in patients with renal osteodystrophy
- Clinical trial of in-situ hybridization method for the rapid diagnosis of sepsis
- Idiopathic portal hypertension associated with high serum titer of autoantibodies and liver dysfunction
- Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
- Efficacy of low-dose, intermittent eel calcitonin treatment for osteoporosis
- Synergistic Enhancement by 12-O-Tetradecanoylphorbol-13-acetate and Dibutyryl cAMP of 1α, 25-Dihydroxyvitamin D_3 Actionin Human Promyelocytic Leukemic HL-60 Cells
- Efficacy and safety of oral falecalcitriol in reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism
- 67. Studies on Ischemic Heart Disease in Patients with Diabetes Mellitus
- Insulin Secretion in Patients with Hyperthyroidism: in Relation to Abnormalities in Carbohydrate Metabolism
- Closer Correlation between Serum Triiodothyronine and Basal Metabolic Rate during Antithyroid Drug Treatment in Patients with Graves Disease
- Effect of Calcitonin and Hexestrol on Urinary Excretion of Hydroxyproline in a Patient with Prostatic Cancer and Bone Metastases
- Statement on the diagnosis and management of osteoporosis from the Consensus Development Conference at the Second International Conference on Osteoporosis,Osaka 1997
- A Case Report on Disequilibrium Hypercalcemia in Hyperthyroidism : Comparison of Calcium Metabolism with Other Patients with Hyperthyroidism
- Effect of Corticosteroids in 10 Cases of Methimazole-Induced Agranulocytosis
- Plasma Active and Inactive Renin in Patients with Diabetes Mellitus
- Preventive Effect of Salmon Calcitonin on Restraint-Induced Gastric Ulcer in Rats
- Plasma Inactive Renin in Patients with Diabetes Mellitus: Effects of Standing and the Relation to Serum Protease Inhibitor
- Secretion of Gastrin and Calcitonin after Ingestion of Meat Extract in Patients with Peptic Ulcer
- A Case Report of Turner's Sydrome with Ring X Chromosome
- Effects of Uremic Serum on 1, 25-Dihydroxyvitamin D3-Induced Differentiation of a Human Promyelocytic Leukemia Cell Line, HL-60
- Lipoprotein Metabolism in Normolipidemic Obese Women during Very Low Calorie Diet:Changes in High Density Lipoprotein
- Effects of Dietary Phosphorus Restriction on Secondary Hyperparathyroidism in Hemodialysis Patients during Intermittent Oral High-dose 1, 25(OH)2D3 Treatment
- Obesity as a Determinant of Regional Bone Mineral Density
- Bone Mineral Loss in Patients on Maintenance Hemodialysis with Hyperphosphatemia Treated with 1α-Hydroxycholecalciferol and Calcium Carbonate
- Total and Regional Bone Mineral Content in Patients with Non-Insulin Dependent Diabetes Mellitus
- Cardiac Function and Exercise Capacity of Diabetic Patients
- Calcium Metabolism in Diabetes Mellitus
- Nutrition and Renal Osteodystrophy